Kratom exposures reported to United States poison control centers: 2011-2017
- PMID: 30786220
- DOI: 10.1080/15563650.2019.1569236
Kratom exposures reported to United States poison control centers: 2011-2017
Abstract
Context: Kratom, or Mitragyna speciosa, is a plant indigenous to Southeast Asia that has gained national attention in the United States for its increased use in the self-management of opioid withdrawal and pain, as well as for concerns about its safety. Methods: This study analyzes exposures to kratom reported to poison control centers (PCCs) in the United States during 2011-2017 from the National Poison Data System (NPDS). Discussion: From 2011 through 2017, 1807 kratom exposures were reported to United States PCCs. Almost two-thirds (65.0%) of these exposures occurred during 2016-2017. Most exposures occurred among adults ≥20 years (88.9%), males (70.8%), at a residence (86.1%), and were intentional (74.3%). Among first-ranked kratom exposures, 31.8% resulted in admission to a health care facility (HCF) and 51.9% in a serious medical outcome. Multiple-substance exposures were associated with greater odds of admission to a HCF (OR: 2.80; 95% CI: 2.21-3.55) and a serious medical outcome (OR: 2.25; 95% CI: 1.77-2.85) compared with single-substance exposures. There were 11 deaths associated with kratom exposure, including two that occurred after exposure to kratom only. Among kratom-only exposures, 86.1% resulted in one or more clinical effects. The most common clinical effects were agitation/irritability (22.9%) and tachycardia (21.4%). There were seven neonatal exposures, including five experiencing withdrawal. Conclusions: Kratom is associated with a variety of serious medical outcomes, especially when used with other substances. More research is needed to define the human response to kratom. Increased regulation of kratom products would help guarantee product quality and safety. Individuals who choose to use kratom should be educated about its potential risks, including the dangers of using it in combination with other substances.
Keywords: Kratom; National Poison Data System; dietary supplement; poison control center; poisoning.
Similar articles
-
Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers - United States, 2010-2015.MMWR Morb Mortal Wkly Rep. 2016 Jul 29;65(29):748-9. doi: 10.15585/mmwr.mm6529a4. MMWR Morb Mortal Wkly Rep. 2016. PMID: 27466822
-
A comparative analysis of kratom exposure cases in Thailand and the United States from 2010-2017.Am J Drug Alcohol Abuse. 2021 Jan 2;47(1):74-83. doi: 10.1080/00952990.2020.1836185. Epub 2020 Nov 24. Am J Drug Alcohol Abuse. 2021. PMID: 33232183
-
Kratom exposures among older adults reported to U.S. poison centers, 2014-2019.J Am Geriatr Soc. 2021 Aug;69(8):2176-2184. doi: 10.1111/jgs.17326. Epub 2021 Jun 18. J Am Geriatr Soc. 2021. PMID: 34143890
-
Kratom Use and Toxicities in the United States.Pharmacotherapy. 2019 Jul;39(7):775-777. doi: 10.1002/phar.2280. Epub 2019 Jun 13. Pharmacotherapy. 2019. PMID: 31099038 Review.
-
Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects.J Am Osteopath Assoc. 2012 Dec;112(12):792-9. J Am Osteopath Assoc. 2012. PMID: 23212430 Review.
Cited by
-
Kratom safety and toxicology in the public health context: research needs to better inform regulation.Front Pharmacol. 2024 Jun 3;15:1403140. doi: 10.3389/fphar.2024.1403140. eCollection 2024. Front Pharmacol. 2024. PMID: 38887550 Free PMC article. Review.
-
Endogenous Opioid Activity as the Mechanism of Action for Mitragyna speciosa (Kratom): The Current State of the Evidence.Adv Neurobiol. 2024;35:287-313. doi: 10.1007/978-3-031-45493-6_15. Adv Neurobiol. 2024. PMID: 38874729 Review.
-
Kratom as a potential substance use disorder harm reduction agent.Front Public Health. 2024 May 30;12:1416689. doi: 10.3389/fpubh.2024.1416689. eCollection 2024. Front Public Health. 2024. PMID: 38873312 Free PMC article. Review.
-
The Complexities of Kratom: Insights on an Increasingly Frequent Clinical Encounter.Cureus. 2024 May 4;16(5):e59650. doi: 10.7759/cureus.59650. eCollection 2024 May. Cureus. 2024. PMID: 38832209 Free PMC article.
-
Effects of Itraconazole on Pharmacokinetics of Mitragynine and 7-Hydroxymitragynine in Healthy Volunteers.ACS Pharmacol Transl Sci. 2024 Feb 20;7(3):823-833. doi: 10.1021/acsptsci.3c00335. eCollection 2024 Mar 8. ACS Pharmacol Transl Sci. 2024. PMID: 38481700
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical